Application 021319

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AVODARTDUTASTERIDECAPSULE;ORAL0.5MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0173-0712AVODARTdutasterideGlaxoSmithKline LLCNDACurrent
0173-0712AVODARTdutasterideGlaxoSmithKline LLCNDACurrent
0173-0712AVODARTdutasterideGlaxoSmithKline LLCNDACurrent
0173-0712AVODARTdutasterideGlaxoSmithKline LLCNDACurrent
69784-712AVODARTdutasterideWoodward Pharma Services LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
61767SUPPL2020-02-04
61751SUPPL2020-01-31
27474SUPPL2013-05-02
27473SUPPL2013-05-02
15185SUPPL2013-05-01
15184SUPPL2013-05-01
27472SUPPL2012-06-29
36649SUPPL2012-06-28
44115ORIG2011-12-20
36648SUPPL2011-06-10
27471SUPPL2011-06-10
15183SUPPL2011-06-10
5024SUPPL2011-06-10
27470SUPPL2010-09-13
36647SUPPL2010-09-10
36646SUPPL2010-06-24
5023SUPPL2010-06-18
24192SUPPL2008-07-17
15181SUPPL2008-06-26
5021SUPPL2008-06-23
5022SUPPL2008-04-02
15182SUPPL2008-04-01
27469SUPPL2006-01-06
27468SUPPL2004-09-15
15180SUPPL2004-09-15
15179SUPPL2004-08-06
5020SUPPL2004-08-06
27467SUPPL2004-03-19
36645SUPPL2002-10-09
5019SUPPL2002-10-09
36644ORIG2001-11-20
21596ORIG2001-11-20
5018ORIG2001-11-20